Search results for " Liv"

showing 10 items of 2456 documents

Steatosis affects the performance of liver stiffness measurement for fibrosis assessment in patients with genotype 1 chronic hepatitis C.

2014

Background & Aims: In Chronic Hepatitis C (CHC), the influence of steatosis on liver stiffness measurement (LSM) is still debated. We assessed the impact of steatosis and its ultrasonographical sign – bright liver echo pattern (BLEP) – on LSM values and on transient elastography (TE) accuracy for the diagnosis of liver fibrosis, in a cohort of consecutive patients with Genotype 1 (G1) CHC. Methods: Patients (n = 618) were assessed by clinical, ultrasonographic and histological (Scheuer score) features. TE was performed using the M probe. Results: Male gender (p = 0.04), steatosis as continuous variable (p <0.001), severity of necroinflammation (p = 0.02) and stage of fibrosis (p <0.001) wer…

AdultLiver CirrhosisMalemedicine.medical_specialtyCirrhosisGenotypeBiopsyComorbidityHepacivirusSettore MED/08 - Anatomia PatologicaGastroenterologySensitivity and SpecificitySeverity of Illness IndexCohort StudiesFibrosisInternal medicineUltrasoundmedicineHumansNon-invasiveEvaluationAgedRetrospective StudiesUltrasonographySettore MED/12 - GastroenterologiaCirrhosiHepatologymedicine.diagnostic_testbusiness.industryFatty liverHepatitis CHepatitis C ChronicMiddle Agedmedicine.diseaseElasticityFatty LiverLiverLiver biopsyCohortFibroscan®Cirrhosis; Evaluation; Fibroscan®; Non-invasive; UltrasoundFemaleSteatosisbusinessTransient elastographyJournal of hepatology
researchProduct

Long-term follow-up of hepatitis C virus-positive patients with persistently normal serum transaminases

2013

Material and methods. This study prospectively evaluated the progression of liver disease in a group of anti-HCV-positive patients with persistently normal ALT levels (PNALT) who were HCV-RNA positive. Patients selected for this study were those who presented with PNALT according to the Italian Association for the Study of the Liver (AISF) criteria in the year 1995/96 and underwent liver biopsy. They were divided into two groups according to their ALT evolution. Forty-five patients were included in this study. Results. After a median follow-up time of 180 months twenty-five of them maintained PNALT, but two of these developed liver cirrhosis (LC) in a mean time of 174 and 202 months, respec…

AdultLiver CirrhosisMalemedicine.medical_specialtyCirrhosisLong term follow upSpecialties of internal medicineNormal serumChronic hepatitis CGastroenterologyAntiviral AgentsBody Mass IndexLiver diseaseInterferon treatmentInternal medicinemedicineHumansLongitudinal StudiesProspective StudiesUltrasonography Doppler ColorChronic hepatitis C. Persistently normal transaminases. Liver histology. Progression of disease. Interferon treatment.Proportional Hazards ModelsHepatologymedicine.diagnostic_testbusiness.industrySignificant differenceHistologyAlanine TransaminaseGeneral MedicineHepatitis C AntibodiesHepatitis C ChronicMiddle Agedmedicine.diseaseSurgeryHepatitis C Virus PositiveLiverRC581-951Liver biopsyDisease ProgressionElasticity Imaging TechniquesRNA ViralFemaleBiopsy Large-Core NeedlePersistently normal transaminasesbusinessLiver histologyProgression of disease
researchProduct

Computer-assisted image analysis of liver collagen: relationship to Ishak scoring and hepatic venous pressure gradient.

2009

Histopathological scoring of disease stage uses descriptive categories without measuring the amount of fibrosis. Collagen, the major component of fibrous tissue, can be quantified by computer-assisted digital image analysis (DIA) using histological sections. We determined relationships between DIA, Ishak stage, and hepatic venous pressure gradient (HVPG) reflecting severity of fibrosis. One hundred fifteen patients with hepatitis C virus (HCV) who had undergone transplantation had 250 consecutive transjugular liver biopsies combined with HVPG (median length, 22 mm; median total portal tracts, 12), evaluated using the Ishak system and stained with Sirus red for DIA. Liver collagen was expres…

AdultLiver CirrhosisMalemedicine.medical_specialtyCirrhosismedicine.medical_treatmentPortal venous pressureImage ProcessingBiopsyLiver transplantationHepatic VeinsGastroenterologyComputer-AssistedInternal medicineBiopsymedicineImage Processing Computer-AssistedHumansProspective StudiesAgedHepatologymedicine.diagnostic_testbusiness.industryHepatologyMiddle Agedmedicine.diseaseHepatitis CConfidence intervalSurgeryLiver TransplantationTransplantationLogistic ModelsLiverAdult; Aged; Biopsy; Collagen; Female; Hepatic Veins; Hepatitis C; Humans; Liver; Liver Cirrhosis; Liver Transplantation; Logistic Models; Male; Middle Aged; Prospective Studies; Venous Pressure; Image Processing Computer-AssistedFemaleCollagenTransient elastographybusinessVenous Pressurecollagen proportionate area HVPG liver fibrosisHepatology (Baltimore, Md.)
researchProduct

Focal confluent fibrosis in cirrhotic liver: natural history studied with serial CT.

2009

The objective of this study was to assess the long-term natural history of focal confluent fibrosis in cirrhotic liver with CT.Two radiologists retrospectively reviewed in consensus 118 liver CT examinations in 26 patients (19 men, seven women; age range, 32-68 years; mean age, 50 years) performed over approximately 6 years. Helical CT scans were obtained before and 30-35 and 65-70 seconds after injection of 125-150 mL of contrast medium at a rate of 4-5 mL/s. Proof of cirrhosis was based on liver transplantation (n = 6), biopsy (n = 9), or imaging findings (n = 11). The number, location, and attenuation of fibrotic lesions and presence of trapped vessels were evaluated. Variation of hepati…

AdultLiver CirrhosisMalemedicine.medical_specialtyCirrhotic liverCirrhosismedicine.medical_treatmentContrast MediaIothalamate MeglumineLiver transplantationFibrosisTriiodobenzoic AcidsBiopsymedicineHumansRadiology Nuclear Medicine and imagingAgedRetrospective Studiesmedicine.diagnostic_testbusiness.industryGeneral MedicineMiddle Agedmedicine.diseaseHelical ctNatural historyContrast mediumDisease ProgressionLinear ModelsRadiographic Image Interpretation Computer-AssistedFemaleRadiologybusinessTomography Spiral ComputedAJR. American journal of roentgenology
researchProduct

Utility and appropriateness of the fatty liver inhibition of progression (FLIP) algorithm and steatosis, activity, and fibrosis (SAF) score in the ev…

2013

Biopsy is still the gold standard for the diagnosis of nonalcoholic steatohepatitis but the definition may vary among pathologists, a drawback especially in evaluation of biopsies for clinical trials. We previously developed a scoring system (steatosis, activity, fibrosis [SAF]) allowing the use of an algorithm (fatty liver inhibition of progression [FLIP]) for the classification of liver injury in morbid obesity. The aim of this study was to determine whether the use of the SAF score and FLIP algorithm can decrease interobserver variations among pathologists. In a first session, pathologists categorized 40 liver biopsies of patients with nonalcoholic fatty liver disease (NAFLD) according t…

AdultLiver CirrhosisMalemedicine.medical_specialtyConcordanceBiopsySettore MED/08 - Anatomia PatologicaSeverity of Illness IndexFibrosisNon-alcoholic Fatty Liver DiseaseInternal medicineSAF steatosis activity fibrosis.Nonalcoholic fatty liver diseaseBiopsyNAS nonalcoholic steatohepatitis activity scoremedicineHumansAgedObserver VariationHepatologymedicine.diagnostic_testbusiness.industryFatty liverGold standard (test)HepatologyMiddle Agedmedicine.diseaseFatty LiverLiverNASH nonalcoholic steatohepatitiDisease ProgressionFemaleNAFLD nonalcoholic fatty liver diseaseSteatosisbusinessAlgorithmAlgorithmsHepatology (Baltimore, Md.)
researchProduct

Insulin resistance is a major determinant of liver stiffness in nondiabetic patients with HCV genotype 1 chronic hepatitis.

2009

BACKGROUND: In patients with chronic hepatitis C (CHC), liver stiffness measurement (LSM) by transient elastography (TE), is closely related to the stage of fibrosis, but may be affected by necroinflammation. Other factors, such as insulin resistance (IR), might influence the performance of LSM. AIMS: To evaluate in a cohort of nondiabetic patients with genotype 1 CHC, whether IR and other anthropometric, biochemical, metabolic and histological factors contribute to LSM and to identify the best cut-off values of LSM for predicting different stages of fibrosis. METHODS: Nondiabetic patients with genotype 1 CHC (n = 156) were evaluated by liver biopsy (Metavir score), anthropometric, biochemi…

AdultLiver CirrhosisMalemedicine.medical_specialtyGenotypemedicine.medical_treatmentHepatitis C virusBiopsySettore MED/08 - Anatomia Patologicamedicine.disease_causeGastroenterologyYoung AdultInsulin resistanceFibrosisRisk FactorsInternal medicinemedicineHumansPharmacology (medical)AgedHepatitisAged 80 and overSettore MED/12 - GastroenterologiaHepatologymedicine.diagnostic_testbusiness.industryInsulinGastroenterologyHepatitis CHepatitis C ChronicMiddle Agedmedicine.diseaseEndocrinologyLiverLiver biopsyinsulin resistance liver stiffnessElasticity Imaging TechniquesFemaleInsulin ResistanceTransient elastographybusinessAlimentary pharmacologytherapeutics
researchProduct

Evaluating the association of serum ferritin and hepatic iron with disease severity in non‐alcoholic fatty liver disease

2019

Background & Aims Hyperferritinemia, with or without increased hepatic iron, represents a common finding in non‐alcoholic fatty liver disease (NAFLD). However, it is unclear whether it reflects hepatic inflammation or true iron‐overload and, in case the latter is confirmed, whether this influences disease progression. We therefore explored the association between serum ferritin, degree and pattern of hepatic iron deposition and liver disease severity in patients with NAFLD. Methods We selected 468 patients with biopsy‐proven NAFLD from 2 European centres. Iron, hepatic and metabolic parameters were collected at the time of liver biopsy. Iron deposits in hepatocytes and reticuloendothelial c…

AdultLiver CirrhosisMalemedicine.medical_specialtyIron OverloadBiopsyGastroenterologyhistology03 medical and health sciencesLiver diseaseiron0302 clinical medicineFibrosisInternal medicinemedicineHumansRetrospective StudiesMetabolic SyndromeHepatologymedicine.diagnostic_testbiologybusiness.industryferritinFatty livernon-alcoholic fatty liver diseaseMononuclear phagocyte systemMiddle Agedmedicine.diseaseFerritinLogistic ModelsLiver030220 oncology & carcinogenesisLiver biopsyFerritinsDisease Progressionbiology.proteinFemale030211 gastroenterology & hepatologyAlcoholic fatty liverferritin; histology; iron; non-alcoholic fatty liver diseaseSteatohepatitisbusinessLiver International
researchProduct

Serial combination of non-invasive tools improves the diagnostic accuracy of severe liver fibrosis in patients with NAFLD

2017

SummaryBackground The accuracy of available non-invasive tools for staging severe fibrosis in patients with nonalcoholic fatty liver disease (NAFLD) is still limited. Aim To assess the diagnostic performance of paired or serial combination of non-invasive tools in NAFLD patients. Methods We analysed data from 741 patients with a histological diagnosis of NAFLD. The GGT/PLT, APRI, AST/ALT, BARD, FIB-4, and NAFLD Fibrosis Score (NFS) scores were calculated according to published algorithms. Liver stiffness measurement (LSM) was performed by FibroScan. Results LSM, NFS and FIB-4 were the best non-invasive tools for staging F3-F4 fibrosis (AUC 0.863, 0.774, and 0.792, respectively), with LSM ha…

AdultLiver CirrhosisMalemedicine.medical_specialtyLiver fibrosisDiagnostic accuracySensitivity and SpecificityGastroenterology03 medical and health sciences0302 clinical medicineNon-alcoholic Fatty Liver DiseaseLiver stiffnessFibrosisInternal medicineHistological diagnosisNonalcoholic fatty liver diseasemedicineHumansPharmacology (medical)In patientAgedHepatologybusiness.industryNon invasiveGastroenterologyMiddle Agedmedicine.disease030220 oncology & carcinogenesisFemale030211 gastroenterology & hepatologybusinessAlgorithmsAlimentary Pharmacology &amp; Therapeutics
researchProduct

Clinical Predictors for Poor Quality of Life in Patients With Covert Hepatic Encephalopathy.

2018

Background Current EASL/AASLD guidelines recommend treatment of covert hepatic encephalopathy (HE) only in symptomatic patients, for example, in those with impaired quality of life or with affected driving abilities. Goals Because testing for impaired quality of life is time consuming, the aim of the present study was to identify simple clinical predictors for poor quality of life in patients with covert HE (CHE). Study In total, 139 cirrhotic in- and outpatients without a history of overt hepatic encephalopathy were enrolled. Diagnosis of HE grade 1 (HE1) was diagnosed clinically according to the West-Haven Criteria. Critical flicker frequency and the Psychometric Hepatic Encephalopathy Sc…

AdultLiver CirrhosisMalemedicine.medical_specialtyMultivariate analysisPsychometricsMEDLINEFlicker fusion thresholdChronic liver diseaseSex FactorsQuality of lifeInternal medicineSurveys and QuestionnairesmedicineHumansIn patientProspective StudiesHepatic encephalopathyAgedAged 80 and overbusiness.industryGastroenterologyMiddle Agedmedicine.diseasePrognosisCovertHepatic EncephalopathyPractice Guidelines as TopicQuality of LifeAccidental FallsFemalebusinessJournal of clinical gastroenterology
researchProduct

The combination of liver stiffness measurement and NAFLD fibrosis score improves the noninvasive diagnostic accuracy for severe liver fibrosis in pat…

2014

Background & Aims The accuracy of noninvasive tools for the diagnosis of severe fibrosis in patients with nonalcoholic fatty liver disease(NAFLD) in clinical practice is still limited. We aimed at assessing the diagnostic performance of combined noninvasive tools in two independent cohorts of Italian NAFLD patients. Methods We analysed data from 321 Italian patients(179 Sicilian-training cohort, and 142 northern Italy-validation cohort) with an histological diagnosis of NAFLD. Severe fibrosis was defined as fibrosis ≥ F3 according to Kleiner classification. The APRI, AST/ALT, BARD, FIB-4, and NFS scores were calculated according to published algorithms. Liver stiffness measurement(LSM) was …

AdultLiver CirrhosisMalemedicine.medical_specialtyPathologyAdolescentLSM ; NAFLD ; NFSBiopsySettore MED/08 - Anatomia PatologicaGastroenterologySeverity of Illness IndexLSM; NAFLD; NFS; Adolescent; Adult; Aged; Alanine Transaminase; Area Under Curve; Aspartate Aminotransferases; Biopsy; Female; Humans; Italy; Liver; Liver Cirrhosis; Male; Middle Aged; Non-alcoholic Fatty Liver Disease; Retrospective Studies; Young Adult; Severity of Illness Index; Hepatology; Medicine (all)Young AdultFibrosisNon-alcoholic Fatty Liver DiseaseInternal medicineNAFLDNonalcoholic fatty liver diseaseSeverity of illnessBiopsyNFSmedicineHumansLSMAspartate AminotransferasesAgedRetrospective StudiesSettore MED/12 - Gastroenterologiabiologymedicine.diagnostic_testHepatologybusiness.industryMedicine (all)Retrospective cohort studyAlanine TransaminaseHepatologyMiddle Agedmedicine.diseaseAlanine transaminaseItalyLiverArea Under CurveCohortbiology.proteinFemalebusinessLiver international : official journal of the International Association for the Study of the Liver
researchProduct